ribavirin treatment chronic hepat oral ribavirin therapi chronic hepat infect pilot studi patient patient men women mean age year biopsy-proven chronic non-a non-b hepat posit antibodi viru treatment oral ribavirin mg day divid dose week median serum alanin aminotransferas concentr patient enrol mu kat/l mu week treatment week end treatment median serum alanin aminotransferas concentr differ treatment side-effect mild revers cessat therapi ribavirin first drug effect oral treatment chronic hepat control trial combin interferon alpha 